Results 71 to 80 of about 7,921 (224)

Beyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study

open access: yesEpilepsia, EarlyView.
Abstract Objective Cenobamate is approved for treatment of focal seizures in adults, but evidence on non‐seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal‐onsEt SeizureS (BLESS) study evaluated patient‐ and clinician‐reported outcomes for up to 52 weeks of cenobamate treatment.
Simona Lattanzi   +206 more
wiley   +1 more source

Concise Synthesis of Lacosamide with High Chiral Purity

open access: yes, 2019
An efficient synthesis process of an antiepileptic drug, lacosamide, with high chiral purity has been developed. A series of acids were screened to form salts with the key intermediate 4, and phosphoric acid, an inexpensive and achiral reagent, turned ...
Jiang-Tao Yang (1493017)   +15 more
core   +1 more source

Statin use and risk of remote seizure after first new onset status epilepticus

open access: yesEpilepsia, EarlyView.
Abstract Objective Preclinical evidence supports the role of statins as antiepileptogenic agents. In this study, we investigated the risk of remote unprovoked seizures (RS) according to the use of statin therapy in a cohort of first‐ever status epilepticus (SE) survivors. Methods Retrospective analysis was made of adult patients (age ≥ 14 years) with a
Niccolò Orlandi   +12 more
wiley   +1 more source

Severe skeletal fragility in SCN8A‐related developmental and epileptic encephalopathy

open access: yesEpilepsia, EarlyView.
Abstract In this child with a phenotype compatible with the SCN8A gain‐of‐function spectrum, more than 20 bone fractures were documented. Together with previously reported cases, these observations raise the possibility that skeletal fragility may represent an underrecognized feature of the clinical spectrum associated with pathogenic SCN8A variants ...
Adélia Maria de Miranda Henriques‐Souza   +1 more
wiley   +1 more source

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels

open access: yes, 2007
We hypothesized that lacosamide modulates voltage-gated sodium channels (VGSCs) at clinical concentrations (32-100 μM). Lacosamide reduced spiking evoked in cultured rat cortical neurons by 30-s depolarizing ramps but not by 1-s ramps.
G. Lees   +7 more
core   +1 more source

Persistence of electroclinical findings in an adult patient with SETD1B‐related epilepsy

open access: yes
Epileptic Disorders, EarlyView.
Rohan Shankar   +2 more
wiley   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Data from: Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures [PDF]

open access: yes, 2019
Objective: To evaluate efficacy and tolerability of adjunctive lacosamide in children and adolescents with uncontrolled focal (partial-onset) seizures. Methods: Double-blind trial (SP0969; NCT01921205) of patients (≥4 to
Scheffer, Ingrid E.   +27 more
core   +1 more source

Temporal lobe epilepsy with bilateral amygdala enlargement mimicking behavioral variant frontotemporal dementia

open access: yes
Epileptic Disorders, EarlyView.
Kentaro Tokumoto   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy